| Begin Again Counseling Llc | |
|
2305 Towle St Falls City NE 68355-1561 | |
| (402) 480-0185 | |
| Not Available |
| Full Name | Begin Again Counseling Llc |
|---|---|
| Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
| Location | 2305 Towle St, Falls City, Nebraska |
| Authorized Official Name and Position | Laura Renee Bartek (OWNER) |
| Authorized Official Contact | 4024800185 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Begin Again Counseling Llc 2305 Towle St Falls City NE 68355-1561 Ph: (402) 480-0185 | Begin Again Counseling Llc 2305 Towle St Falls City NE 68355-1561 Ph: (402) 480-0185 |
| NPI Number | 1225802549 |
|---|---|
| Provider Enumeration Date | 11/07/2023 |
| Last Update Date | 11/07/2023 |
| Certification Date | 11/07/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225802549 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
Kids treated more than 150 days after an Anterior Cruciate Ligament (ACL) injury have higher rates of other knee injuries, including medial meniscal tears, say researchers presenting at the American Orthopaedic Society for Sports Medicine's (AOSSM) Specialty Day in San Francisco, CA.
In chronic kidney disease patients, different levels of anemia treatment have a beneficial effect on the heart and improve quality of life, according to a pair of studies appearing in the April 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).
The U.S. Joint Commission recently approved new hospital accreditation measures related to alcohol screening, brief intervention, and referral to treatment (SBIRT) for all hospitalized patients. Yet little is known about the effectiveness of brief interventions (BIs) or inpatient acceptability of SBIRT when performed by healthcare professionals other than physicians. A new study has found high hospital-patient acceptability of and comfort with nurse-delivered SBIRT.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 5 days ago